Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Higher Myocardial and Skeletal Muscle Microvascular Flow in Sickle Cell Disease Patients on Hydroxyurea

Caterina P. Minniti, MD, Vandana Sachdev, MD, Hannoush Hwaida, MD, Stanislav Sidenko, MD, Myron A Waclawiw, MD, Brenneman Cyndy, MD, Andrew E Arai, MD, Gregory J. Kato, MD, Jonathan R. Lindner, MD

Blood (2016) 128 (22): 1020.

https://doi.org/10.1182/blood.V128.22.1020.1020

Published: 2016

Journal Articles

Activated Human iNKT Cells in Pediatric Sickle Cell Disease Patients and in Culture Upregulate Ectonucleotidase CD39 and Adenosine a 2A Receptor

Jennifer C. Yu, MD, Gene W. Lin, MD PhD, Jenny Kim, MD, Joel Linden, PhD

Blood (2014) 124 (21): 2734.

https://doi.org/10.1182/blood.V124.21.2734.2734

Published: 2014

Journal Articles

Contrast-Enhanced Ultrasound Detects Differences in Microvascular Blood Flow in Adults with Sickle Cell Disease Administered Regadenoson

Jonathan R. Lindner, MD, Michael Widlansky, MD, Melinda D. Wu, MD, Jillian Dargatz, RN, Leanne M. Harmann, RDCS, RDMS, RVT, Todd Belcik, BS, RCS, RDCS, Donna S. Neuberg, ScD, David G. Nathan, MD, Joel Linden, PhD, Joshua J. Field, MD MS

Blood (2014) 124 (21): 2705.

https://doi.org/10.1182/blood.V124.21.2705.2705

Published: 2014

Journal Articles

NF-κB Activation Mediates Induction Of Anti-Inflammatory Adenosine A2A Receptors In iNKT Cells Of Sickle Cell Patients During Vaso-Occlusive Episodes and Upon Activation Of Cultured Human iNKT Cells

Joel Linden, PhD, Gene Lin, MD, PhD, Jennifer C. Yu, MD, Donna S. Neuberg, ScD, David G. Nathan, MD, Joshua J. Field, MD, MS

Blood (2013) 122 (21): 975.

https://doi.org/10.1182/blood.V122.21.975.975

Published: 2013

Journal Articles

Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A 2A receptor agonist regadenoson

Joshua J. Field, Gene Lin, Maureen M. Okam, Elaine Majerus, Jeffrey Keefer, Onyinye Onyekwere, Ainsley Ross, Federico Campigotto, Donna Neuberg, Joel Linden, David G. Nathan

Blood (2013) 121 (17): 3329–3334.

https://doi.org/10.1182/blood-2012-11-465963

Published: 2013

Includes: Supplemental data

Journal Articles

Regadenoson, An Adenosine 2A Receptor Agonist, Is Safe and Inhibits Invariant NKT Cells in Sickle Cell Disease

Joshua Field, MD, MS, Gene Lin, MD, PhD, Maureen Okam, MD, MPH, Elaine Majerus, MD, PhD, Onyinye Onyekwere, MD, MS, Ainsley Ross, BA, Donna Neuberg, ScD, Federico Campigotto, MS, David G. Nathan, MD, Joel Linden, PhD

Blood (2011) 118 (21): 849.

https://doi.org/10.1182/blood.V118.21.849.849

Published: 2011

NARROW

Higher Myocardial and Skeletal Muscle Microvascular Flow in Sickle Cell Disease Patients on Hydroxyurea

Activated Human iNKT Cells in Pediatric Sickle Cell Disease Patients and in Culture Upregulate Ectonucleotidase CD39 and Adenosine a 2A Receptor

Contrast-Enhanced Ultrasound Detects Differences in Microvascular Blood Flow in Adults with Sickle Cell Disease Administered Regadenoson

NF-κB Activation Mediates Induction Of Anti-Inflammatory Adenosine A2A Receptors In iNKT Cells Of Sickle Cell Patients During Vaso-Occlusive Episodes and Upon Activation Of Cultured Human iNKT Cells

Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A 2A receptor agonist regadenoson

Regadenoson, An Adenosine 2A Receptor Agonist, Is Safe and Inhibits Invariant NKT Cells in Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Higher Myocardial and Skeletal Muscle Microvascular Flow in Sickle Cell Disease Patients on Hydroxyurea

Activated Human iNKT Cells in Pediatric Sickle Cell Disease Patients and in Culture Upregulate Ectonucleotidase CD39 and Adenosine a 2A Receptor

Contrast-Enhanced Ultrasound Detects Differences in Microvascular Blood Flow in Adults with Sickle Cell Disease Administered Regadenoson

NF-κB Activation Mediates Induction Of Anti-Inflammatory Adenosine A2A Receptors In iNKT Cells Of Sickle Cell Patients During Vaso-Occlusive Episodes and Upon Activation Of Cultured Human iNKT Cells

Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A 2A receptor agonist regadenoson

Regadenoson, An Adenosine 2A Receptor Agonist, Is Safe and Inhibits Invariant NKT Cells in Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only